FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| "Fresenius Kabi Compounding, LLC(080570297)" | 71506-014 | 71506-014-58 | Vancomycin Hydrochloride | 750 mg/250 mL | 2020-2 | valid | 2026-11-12 | ||
| "Fresenius Kabi Compounding, LLC(080570297)" | 71506-015 | 71506-015-58 | Vancomycin Hydrochloride | 1.25 g/250 mL | 2020-2 | valid | 2026-11-12 | ||
| "Fresenius Kabi Compounding, LLC(080570297)" | 71506-016 | 71506-016-59 | Vancomycin Hydrochloride | 1.5 g/500 mL | 2020-2 | valid | 2026-11-12 | ||
| "Fresenius Kabi Compounding, LLC(080570297)" | 71506-017 | 71506-017-59 | Vancomycin Hydrochloride | 1.75 g/500 mL | 2020-2 | valid | 2026-11-12 | ||
| "Fresenius Kabi Compounding, LLC(080570297)" | 71506-018 | 71506-018-58 | Vancomycin Hydrochloride | 1 g/250 mL | 2020-2 | valid | 2026-11-12 | ||
| "Fresenius Kabi Compounding, LLC(080570297)" | 71506-019 | 71506-019-59 | Vancomycin Hydrochloride | 2 g/500 mL | 2020-2 | valid | 2026-11-12 | ||
| "Fresenius Kabi Compounding, LLC(080570297)" | 71506-020 | 71506-020-56 | Calcium Gluconate | 1 g/100 mL | 2020-2 | valid | 2026-11-12 | ||
| "Fresenius Kabi Compounding, LLC(080570297)" | 71506-021 | 71506-021-56 | Calcium Gluconate | 2 g/100 mL | 2020-2 | valid | 2026-11-12 | ||
| "Fresenius Kabi Compounding, LLC(080570297)" | 71506-022 | 71506-022-35 | Ephedrine Sulfate | 15 g/3 mL | 2020-2 | valid | 2026-11-12 | ||
| "Fresenius Kabi Compounding, LLC(080570297)" | 71506-035 | 71506-035-56 | Acyclovir Sodium | 200 mg/100 mL | 2020-2 | valid | 2026-11-12 | ||
| "Fresenius Kabi Compounding, LLC(080570297)" | 71506-023 | 71506-023-03 | Glycopyrrolate | .6 mg/3 mL | 2020-2 | valid | 2026-11-12 | ||
| "Imprimis NJOF, LLC(080431967)" | Moxifloxacin Hydrochloride | .8 mg/.8 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Moxifloxacin Hydrochloride | 4 mg/.8 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Moxifloxacin Hydrochloride; Dexamethasone Sodium Phosphate | 5 mg/1 mL; 1 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Nepafenac; Prednisolone Acetate; Moxifloxacin Hydrochloride | 1 mg/1 mL; 10 mg/1 mL; 5 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Nepafenac; Prednisolone Acetate; Moxifloxacin Hydrochloride | 1 mg/1 mL; 10 mg/1 mL; 5 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Ondansetron Hydrochloride; Ketamine Hydrochloride; Midazolam | 2 mg/.165 g; 25 mg/.165 g; 3 mg/.165 g | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Phenylephrine Hydrochloride; Lidocaine Hydrochloride | 15 mg/1 mL; 10 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Phenylephrine Hydrochloride; Tropicamide | 25 mg/1 mL; 10 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Phenylephrine Hydrochloride; Tropicamide | 25 mg/1 mL; 10 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Phenylephrine Hydrochloride; Tropicamide; Proparacaine Hydrochloride; Ketorolac Tromethamine | 25 mg/1 mL; 10 mg/1 mL; 5 mg/1 mL; 5 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Prednisolone Acetate | 10 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Prednisolone Acetate; Moxifloxacin Hydrochloride | 10 mg/1 mL; 5 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Bromfenac Sodium; Prednisolone Acetate | .75 mg/1 mL; 10 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Bromfenac Sodium; Prednisolone Acetate; Moxifloxacin Hydrochloride | .75 mg/1 mL; 10 mg/1 mL; 5 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Bromfenac Sodium; Prednisolone Acetate; Moxifloxacin Hydrochloride | .75 mg/1 mL; 10 mg/1 mL; 5 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Triamcinolone Acetonide; Moxifloxacin Hydrochloride | 15 mg/1 mL; 1 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Cyclosporine | 1 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Dexamethasone Sodium Phosphate; Moxifloxacin Hydrochloride; Ketorolac Tromethamine | 1 mg/1 mL; .5 mg/1 mL; .4 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Lidocaine Hydrochloride; Epinephrine Hydrochloride | 7.5 mg/1 mL; .25 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "IntegraDose Compounding Services, LLC(080467666)" | 71139-6030 | 71139-6030-1 | Fentanyl Citrate | 2500 ug/50 mL | 2020-2 | valid | 2026-11-12 | ||
| "IntegraDose Compounding Services, LLC(080467666)" | 71139-0018 | 71139-0018-1 | Hydromorphone Hydrochloride | 20 mg/100 mL | 2020-2 | valid | 2026-11-12 | ||
| "KRS Global Biotechnology, Inc.(014763459)" | Methylene Blue | 10 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "KRS Global Biotechnology, Inc.(014763459)" | Morphine Sulfate | 1 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "KRS Global Biotechnology, Inc.(014763459)" | Moxifloxacin | 1 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "KRS Global Biotechnology, Inc.(014763459)" | Moxifloxacin | 1 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "KRS Global Biotechnology, Inc.(014763459)" | Neostigmine Methylsulfate | 1 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "KRS Global Biotechnology, Inc.(014763459)" | Neostigmine Methylsulfate | 1 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "KRS Global Biotechnology, Inc.(014763459)" | Norepinephrine | .032 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "KRS Global Biotechnology, Inc.(014763459)" | Norepinephrine | .032 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "KRS Global Biotechnology, Inc.(014763459)" | Norepinephrine | 4 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "KRS Global Biotechnology, Inc.(014763459)" | Norepinephrine | .016 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "KRS Global Biotechnology, Inc.(014763459)" | Norepinephrine | .064 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "KRS Global Biotechnology, Inc.(014763459)" | Norepinephrine | 4 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "KRS Global Biotechnology, Inc.(014763459)" | Norepinephrine | .016 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "KRS Global Biotechnology, Inc.(014763459)" | Phenylephrine Hydrochloride | .08 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "KRS Global Biotechnology, Inc.(014763459)" | Phenylephrine Hydrochloride | .1 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "KRS Global Biotechnology, Inc.(014763459)" | Phenylephrine Hydrochloride | .4 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "KRS Global Biotechnology, Inc.(014763459)" | Phenylephrine Hydrochloride | .16 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 | ||||
| "KRS Global Biotechnology, Inc.(014763459)" | Phenylephrine Hydrochloride; Lidocaine Hydrochloride | 15 mg/1 mL; 10 mg/1 mL | 2020-2 | source_no_ndc | 2026-11-12 |